Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$8,128,309
-$100,518 QoQ
Shares Held
32,005
-4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,237
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $64,915,903 across 12 Drug Manufacturers - General names. JNJ ranks #4 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,349 | $17,210,622 | |
| 2 | ABBV |
AbbVie Inc.
|
52,406 | $13,187,445 | |
| 3 | MRK |
Merck & Co., Inc.
|
80,029 | $10,283,726 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
32,005 | $8,128,309 | |
| 5 | AMGN |
Amgen Inc
|
14,713 | $5,327,871 | |
| 6 | PFE |
Pfizer Inc
|
128,183 | $3,086,646 | |
| 7 | SNY |
Sanofi
|
68,196 | $2,909,240 | |
| 8 | AZN |
Astrazeneca PLC
|
8,294 | $1,572,707 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,128,309 | 32,005 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $8,228,827 | 33,664 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $9,135,807 | 44,145 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $8,188,332 | 44,161 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $6,735,358 | 44,094 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $7,506,913 | 45,266 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $6,876,680 | 47,550 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $7,150,573 | 44,123 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,636,074 | 38,561 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $7,442,839 | 47,050 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $7,441,231 | 47,475 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $7,608,699 | 48,852 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $8,250,509 | 49,846 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $7,592,055 | 48,981 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $8,836,032 | 50,020 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $8,168,979 | 50,006 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $8,732,249 | 49,193 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $9,034,121 | 50,974 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $9,049,602 | 52,900 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $8,374,744 | 51,856 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $8,764,002 | 53,199 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $8,761,005 | 53,307 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $8,004,503 | 50,861 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $7,597,495 | 51,031 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,361,277 | 52,345 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $7,101,213 | 54,154 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||